Belomed S.R.L.

Belomed S.R.L., a Peru-based minority-owned medical and laboratory supplies vendor, serves as a prime contractor providing specialized laboratory reagents, diagnostic consumables, and equipment maintenance services exclusively to the U.S. Navy's Bureau of Medicine and Surgery, operating entirely outside set-aside designations on firm fixed-price purchase orders.

Belomed is a for-profit organization headquartered in San Miguel, Peru (int 3, Juana Riofrio 153, 15087), competing in full-and-open federal procurement with no SBA certifications or set-aside designations across its federal footprint. The vendor's capability portfolio centers on laboratory reagents and consumables — PCR test kits, cytokines, cell culture media, sera, and next-generation sequencing materials — paired with preventive maintenance services for specialized lab equipment including thermal cyclers and Agilent TapeStation systems. Representative work includes a $24,931 annual preventive maintenance contract for NAMRU South facilities in Lima and Iquitos, Peru (awarded September 4, 2025); a $23,404 purchase order for laboratory reagents including PCR kits and cell culture media (May 19, 2025); a $12,956 award for Agilent TapeStation reagents and consumables supporting next-generation sequencing quality control (August 7, 2025); and multiple smaller orders for laboratory supplies, qubit assay tubes, and blocker reagents ranging from $360 to $8,714 issued in April 2026.

Customer concentration is absolute: all 29 awards (100% of awards and $251 thousand in combined potential value) flow to the Department of the Navy's Bureau of Medicine and Surgery, with no other federal agencies in the footprint. The vendor operates no parent vehicles, IDIQs, or standing BPAs; all awards are transactional purchase orders with direct completion dates. Work is performed in Peru, with ultimate completion dates spanning June 2025 through September 2026. Three awards totaling $35 thousand face completion within the next twenty-four months, representing near-term recompete exposure. Belomed operates as a 100% prime contractor with no subcontract relationships in the source data. Award frequency has been episodic: four awards in 2018, ten in 2019, one in 2020, and twelve across 2025–2026, reflecting BUMED's recurrent but unpredictable demand for specialized laboratory supplies and maintenance services at its overseas medical research installations, particularly NAMRU-6 operating in Peru.